Tumour-associated antigens in multiple myeloma

CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Leukemia·2026

Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.

Cell reports. Medicine·2026

CRCI2NA inaugural symposium: A meeting on tumor and immune ecosystems.

Biology of the cell·2024

Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.

HemaSphere·2024

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

Nature cancer·2024

Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.

Haematologica·2024

Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

British journal of haematology·2026

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

British journal of haematology·2026

CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

British journal of haematology·2026

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

British journal of haematology·2026

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

British journal of haematology·2026

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

British journal of haematology·2026

A multitargeting nanoparticle-based vaccine for enhanced anticancer immunotherapy in HER2-Positive breast cancer.

Materials today. Bio·2026

Ferritin heavy chain 1 expression is correlated with plasma cell exhaustion and acts as a prognostic correlative marker in hepatocellular carcinoma.

Frontiers in immunology·2026

Bladder mucosal apoptosis index and quality of life after adjuvant intravesical BCG therapy for non-muscle-invasive bladder cancer: a retrospective propensity-score-matched study.

Frontiers in oncology·2026

Chemotherapy-induced myasthenia gravis presenting as isolated bulbar palsy in a patient with WHO type B3 thymoma: A case report.

Medicine·2026

Tick-borne tularaemia as a differential diagnosis in ulcerative skin infection and regional lymphadenopathy in children: a case report.

Journal of medical case reports·2026

Pancreatic tuberculosis: Likely originating from peripancreatic tuberculous lymphadenitis.

Hepatobiliary & pancreatic diseases international : HBPD INT·2026

Related Experiment Videos

Tumour-associated antigens in multiple myeloma

Related Concept Videos

CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Targeting BCMA in multiple myeloma with a trifunctional NK cell engager.

CRCI2NA inaugural symposium: A meeting on tumor and immune ecosystems.

Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.

Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

A multitargeting nanoparticle-based vaccine for enhanced anticancer immunotherapy in HER2-Positive breast cancer.

Ferritin heavy chain 1 expression is correlated with plasma cell exhaustion and acts as a prognostic correlative marker in hepatocellular carcinoma.

Bladder mucosal apoptosis index and quality of life after adjuvant intravesical BCG therapy for non-muscle-invasive bladder cancer: a retrospective propensity-score-matched study.

Chemotherapy-induced myasthenia gravis presenting as isolated bulbar palsy in a patient with WHO type B3 thymoma: A case report.

Tick-borne tularaemia as a differential diagnosis in ulcerative skin infection and regional lymphadenopathy in children: a case report.

Pancreatic tuberculosis: Likely originating from peripancreatic tuberculous lymphadenitis.

Related Experiment Videos

Tumour-associated antigens in multiple myeloma

Related Concept Videos

Related Articles